8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection.

          Related collections

          Author and article information

          Journal
          Expert Rev Pharmacoecon Outcomes Res
          Expert review of pharmacoeconomics & outcomes research
          Informa UK Limited
          1744-8379
          1473-7167
          2015
          : 15
          : 4
          Affiliations
          [1 ] Department of Pharmacy, Faculty of Medicine, Siriraj Hospital, 2 Prannok road, Siriraj, Bangkoknoi, Bangkok, Thailand 10700.
          Article
          10.1586/14737167.2015.972379
          25327502
          50485413-53b6-498a-a414-5d63a00cbda2
          History

          oxaliplatin,Thailand,adjuvant chemotherapy,cost-utility analysis,stage III colon cancer

          Comments

          Comment on this article